BioCentury | Feb 6, 2012
Company News

Technoclone, Roche deal

...market Technoclone's research use only products in the hemostasis research community. Details were not disclosed. Technoclone GmbH...
BioCentury | May 17, 2004
Politics, Policy & Law

FP-6's Public-Private Networks

...Israel. Two biotechnology companies are participating: Ark Therapeutics Group plc . (LSE:AKT, London, U.K.) and Technoclone GmbH...
...therapeutics that comes out of EVGN during the period of the grant, Martin said. Similarly, Technoclone...
Items per page:
1 - 2 of 2
BioCentury | Feb 6, 2012
Company News

Technoclone, Roche deal

...market Technoclone's research use only products in the hemostasis research community. Details were not disclosed. Technoclone GmbH...
BioCentury | May 17, 2004
Politics, Policy & Law

FP-6's Public-Private Networks

...Israel. Two biotechnology companies are participating: Ark Therapeutics Group plc . (LSE:AKT, London, U.K.) and Technoclone GmbH...
...therapeutics that comes out of EVGN during the period of the grant, Martin said. Similarly, Technoclone...
Items per page:
1 - 2 of 2